Wilson Glynninsider trades

In SEC Form 4 filings, Wilson Glynn is listed as Chief Executive Officer of Caring Brands, Inc. (CABR) and Director of Cadrenal Therapeutics, Inc. (CVKD). Wilson Glynn reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 16.

Companies and roles

Company	Role	Transactions	Last filed
CABRCaring Brands, Inc.	Chief Executive Officer	1	Oct 16
CVKDCadrenal Therapeutics, Inc.	Director	1	Oct 13

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-13

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
CABRCaring Brands, Inc.	Oct 6	Oct 16	A · derivative	75,000	$1.13	$84,750	747,592	No	Form 4
CVKDCadrenal Therapeutics, Inc.	Oct 9	Oct 13	A · derivative	75,000	$0.91	$68,250	75,000	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.